A study of the Ad26.COV2.S vaccine candidate for the prevention of SARS-CoV-2-mediated COVID-19 in adults : A randomized, double-blind, controlled Phase 3 study to assess the efficacy and safety of Ad26.COV2.S for the prevention of SARS-CoV-2-mediated COVID-19 in adults aged 18 years and older

Medienart:

Klinische Studie

Erscheinungsjahr:

2021

Erschienen:

2021

Enthalten in:

WHO International Clinical Trials Registry Platform - (2021) vom: 29. Nov. Zur Gesamtaufnahme - year:2021

Sprache:

Englisch

Links:

Volltext [kostenfrei]

Themen:

610
Medical Condition: COVID-19 (SARS-CoV-2 infection) Infections and Infestations
Phase: Phase 3
Recruitment Status: Recruiting
Study Type: Interventional

Anmerkungen:

WHO International Clinical Trials Registry Platform (https://www.who.int/ictrp/en/), First posted: 04-11-2020, Last updated: 2022-11-24

ICTRP ID:

ISRCTN14722499
2020-003643-29
NCT04614948
Protocol-ID VAC31518COV3009
IRAS 288552
CPMS 46804

Förderinstitution / Projekttitel:

PPN (Katalog-ID):

WHO006997988